1. A Phase I/II Study of a 72-h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma. (1997) Authors: Crawley, Charles R.; Judson, Ian R.; Verrill, Mark; Hill, Catherine; Raynaud, Florence I. Journal: Sarcoma Issue: Volume 1:Number 3/4(1997) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First‐line chemotherapy in advanced intra‐abdominal well‐differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis. Issue 15 (13th May 2022) Authors: Stacchiotti, Silvia; Van der Graaf, Winette T. A.; Sanfilippo, Roberta G.; Marreaud, Sandrine I.; Van Houdt, Winan J.; Judson, Ian R.; Gronchi, Alessandro; Gelderblom, Hans; Litiere, Saskia; Kasper, Bernd Journal: Cancer Issue: Volume 128:Issue 15(2022) Page Start: 2932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors. (20th March 2015) Authors: Lee, Chooi Peng; Taylor, N. Jane; Attard, Gerhardt; Pacey, Simon; Nathan, Paul D.; Bono, Johann S.; Temple, Graham; Bell, Susan; Stefanic, Martin; Stopfer, Peter; Tang, Adrian; Koh, Dow-Mu; Collins, David J.; d'Arcy, James; Padhani, Anwar R.; Leach, Martin O.; Judson, Ian R.; Rustin, Gordon J. Journal: Oncologist Issue: Volume 20:Number 4(2015) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase I Study of Nintedanib Incorporating Dynamic Contrast‐Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors. (20th March 2015) Authors: Lee, Chooi Peng; Taylor, N. Jane; Attard, Gerhardt; Pacey, Simon; Nathan, Paul D.; de Bono, Johann S.; Temple, Graham; Bell, Susan; Stefanic, Martin; Stopfer, Peter; Tang, Adrian; Koh, Dow‐Mu; Collins, David J.; d'Arcy, James; Padhani, Anwar R.; Leach, Martin O.; Judson, Ian R.; Rustin, Gordon J. Journal: Oncologist Issue: Volume 20:Number 4(2015) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Susceptibility of Fibromatosis Cells in Short-Term Culture to Ifosfamide: A Possible Experimental Treatment in Clinically Aggressive Cases. (1999) Authors: Verrill, Mark W.; Coley, Helen M.; Judson, Ian R.; Fisher, Cyril Journal: Sarcoma Issue: Volume 3:Number 2(1999) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations. (17th March 2011) Authors: Olmos, David; Martins, Ana Sofia; Jones, Robin L.; Alam, Salma; Scurr, Michelle; Judson, Ian R. Other Names: Pappo Alberto Academic Editor. Journal: Sarcoma Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations. (3rd May 2011) Authors: Olmos, David; Martins, Ana Sofia; Jones, Robin L.; Alam, Salma; Scurr, Michelle; Judson, Ian R. Other Names: Pappo Alberto Academic Editor. Journal: Sarcoma Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study*. (2nd December 2017) Authors: Gelderblom, Hans; Judson, Ian R.; Benson, Charlotte; Merimsky, Ofer; Grignani, Giovanni; Katz, Daniela; Freivogel, Klaus W.; Stein, Dara; Jobanputra, Minesh; Mungul, Arron; Manson, Stephanie C.; Sanfilippo, Roberta Journal: Acta oncologica Issue: Volume 56:Number 12(2017) Page Start: 1769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Uterine sarcoma dissemination during myomectomy: If not "acceptable collateral damage, " is it possible to mitigate the risk?. Issue 20 (12th June 2014) Authors: Judson, Ian R.; Miah, Aisha B. Journal: Cancer Issue: Volume 120:Issue 20(2014) Page Start: 3100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Uterine sarcoma dissemination during myomectomy: If not "acceptable collateral damage, " is it possible to mitigate the risk?. Issue 20 (12th June 2014) Authors: Judson, Ian R.; Miah, Aisha B. Journal: Cancer Issue: Volume 120:Issue 20(2014) Page Start: 3100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗